Epidemiological assessment of drug-induced disease (Q34079945)

30 July 2017

1 reference

title

Epidemiological assessment of drug-induced disease (English)

1 reference

30 July 2017

1 reference

D W Kaufman

1

1 reference

30 July 2017

S Shapiro

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

356

1 reference

30 July 2017

issue

9238

1 reference

30 July 2017

page(s)

1339-1343

1 reference

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902826-9

7 January 2021

Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902826-9

7 January 2021

Evaluation of case reports of aplastic anemia among patients treated with felbamate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902826-9

7 January 2021

Drug-associated anaphylaxis: 20 years of reporting in The Netherlands (1974-1994) and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902826-9

7 January 2021

Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902826-9

7 January 2021

Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902826-9

7 January 2021

Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902826-9

7 January 2021

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902826-9

7 January 2021

Comparative safety evaluation of non-narcotic analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902826-9

7 January 2021

Update on aspirin in the treatment and prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902826-9

7 January 2021

Nonsteroidal antiinflammatory drugs and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902826-9

7 January 2021

Oral contraceptives and cardiovascular disease (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902826-9

7 January 2021

Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902826-9

7 January 2021

Myocardial infarction in users of low-dose oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902826-9

7 January 2021

Modern oral contraceptives and cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902826-9

7 January 2021

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902826-9

7 January 2021

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902826-9

7 January 2021

10.1016/S0140-6736(00)02826-9

Identifiers

DOI

1 reference

30 July 2017

1 reference